[116 Pages Report] The colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 498.8 Million in 2017 at a CAGR of 6.8% during the forecast period. The base year for this study is 2017 and the forecast period is 2018�2023.

The objectives of this study are as follows:

To define, describe, and forecast the market on the basis of instrument type, instrument portability, application, end user, and region

To forecast the revenue of the market segments in North America, Europe, Asia, and the Rest of the World (RoW)

To identify micromarkets and the drivers, restraints, industry-specific challenges, opportunities, and trends affecting market growth

To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies

To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and R&D activities in the colposcopy market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by instrument portability and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

Various secondary sources such as the World Health Organization (WHO), Food and Drug Administration (FDA), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Royal Australian and New Zealand College of Obstetricians and Gynecologists (RANZCOG), American Society for Colposcopy and Cervical Pathology (ASCCP), European Cervical Cancer Screening Network (ECCSN), American Cancer Society (ACS), Indian Society of Colposcopy and Cervical Pathology (ISCCP), Hong Kong Society for Colposcopy and Cervical Pathology (KKSCCP), Genome Medicine, Mary Ann Liebert, Inc. Publishers, PubMed, have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess the prospects of the colposcopy industry. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany)

Target Audience for this Report:

Manufacturers and vendors of colposcopy

Research associations related to cervical cancer

Various research and consulting firms

Distributors of colposcopy products

Contract manufacturers of colposcopy products

Healthcare institutions

Research institutes

Scope of the Report:

This report categorizes the colposcopy market into the following segments:

By Instrument Type Optical Digital

By Instrument Portability Portable Fixed Handheld

By Application Cervical cancer screening Physical examinations Other applications

By End User Hospitals Clinics Diagnostic centers Other end users

By Region North America US Canada Europe Germany France UK Rest of Europe Asia Rest of the World



Customization Options:

Company Information: Detailed company profiles of five or more market players

Opportunity Assessment: A detailed report underlining the various growth opportunities presented in the market

The global colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market.

The global market is segmented based on instrument type, instrument portability, application, end user, and region. By end user, the market is segmented into hospitals, clinics, diagnostic centers and other end users. Hospitals are expected to hold the largest share of the global market in 2018. Growth in this segment is mainly credited to the growing number of cervical cancer patients across the globe, increasing number of cancer screening initiatives, as well as the rising installation of colposcopes in hospitals across the world.

The colposcopy market by instrument portability is segmented into portable, fixed, and handheld colposcopes. The portable colposcopes segment is estimated to account for the largest share of the global market in 2018. The large share of this segment can be attributed to the advantages of portable colposcopes, which include ease of installation and movement within medical settings, better result reproducibility, and the ability to produce high-definition images and stable cervix examinations.

The global market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR. The large share of the North American Market can primarily be attributed to the high burden of cervical cancer, increasing government initiatives, availability of technologically advanced screening tools, the presence of major players in this region, and the presence of quality healthcare infrastructure.

While the colposcopy market offers lucrative growth opportunities to key players, the availability of alternative methods is expected to limit market growth during the forecast period. The lack of skilled clinical professionals may also challenge market growth to a certain extent.

Major industry players launched innovative products to maintain and improve their position in the market. DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany) have been identified as key players in this market. These companies have broad product portfolios with comprehensive features and also launch innovative products to keep up with the demand s of the market. These leaders also have products for all end users in this market, strong geographical presence, and a focus on continuous product innovation.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst